141 related articles for article (PubMed ID: 9742041)
1. Discoidal niosome based controlled ocular delivery of timolol maleate.
Vyas SP; Mysore N; Jaitely V; Venkatesan N
Pharmazie; 1998 Jul; 53(7):466-9. PubMed ID: 9742041
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
Hegde RR; Bhattacharya SS; Verma A; Ghosh A
Curr Eye Res; 2014 Feb; 39(2):155-63. PubMed ID: 24073659
[TBL] [Abstract][Full Text] [Related]
3. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
[TBL] [Abstract][Full Text] [Related]
4. Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication.
Hathout RM; Gad HA; Abdel-Hafez SM; Nasser N; Khalil N; Ateyya T; Amr A; Yasser N; Nasr S; Metwally AA
Int J Pharm; 2019 Feb; 556():192-199. PubMed ID: 30553005
[TBL] [Abstract][Full Text] [Related]
5. The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits.
Shafaa MW; Sabra NM; Fouad RA
Biopharm Drug Dispos; 2011 Dec; 32(9):507-17. PubMed ID: 22028305
[TBL] [Abstract][Full Text] [Related]
6. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
[TBL] [Abstract][Full Text] [Related]
7. Liposome incorporated ion sensitive in situ gels for opthalmic delivery of timolol maleate.
Yu S; Wang QM; Wang X; Liu D; Zhang W; Ye T; Yang X; Pan W
Int J Pharm; 2015 Mar; 480(1-2):128-36. PubMed ID: 25615987
[TBL] [Abstract][Full Text] [Related]
8. Ocular pharmacokinetic/pharmacodynamic modeling for timolol in rabbits using a telemetry system.
Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
Biol Pharm Bull; 2008 May; 31(5):970-5. PubMed ID: 18451528
[TBL] [Abstract][Full Text] [Related]
9. In Situ Gelling Electrospun Ocular Films Sustain the Intraocular Pressure-Lowering Effect of Timolol Maleate: In Vitro, Ex Vivo, and Pharmacodynamic Assessment.
Andreadis II; Karavasili C; Thomas A; Komnenou A; Tzimtzimis M; Tzetzis D; Andreadis D; Bouropoulos N; Fatouros DG
Mol Pharm; 2022 Jan; 19(1):274-286. PubMed ID: 34877863
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects.
Huang SF; Chen JL; Yeh MK; Chiang CH
J Ocul Pharmacol Ther; 2005 Dec; 21(6):445-53. PubMed ID: 16386086
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of timolol and aceclidine after ocular instillation in the rabbit.
Matera MG; Lampa E; Imperatore A; Berrino L; Russo F; Boldrini E; Rossi F
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):35-42. PubMed ID: 9644717
[TBL] [Abstract][Full Text] [Related]
12. Ocular mini-tablets for controlled release of timolol: evaluation in rabbits.
Chetoni P; Mariotti Bianchi L; Giannaccini B; Saettone MF; Conte U; Sangalli ME
J Ocul Pharmacol Ther; 1996; 12(3):245-52. PubMed ID: 8875330
[TBL] [Abstract][Full Text] [Related]
13. Effects of topical nipradilol and timolol maleate on intraocular pressure, facility of outflow, arterial blood pressure and pulse rate in dogs.
Maehara S; Ono K; Ito N; Tsuzuki K; Seno T; Yokoyama T; Yamashita K; Izumisawa Y; Kotani T
Vet Ophthalmol; 2004; 7(3):147-50. PubMed ID: 15091320
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
Chiang CH; Ho JI; Chen JL
J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
[TBL] [Abstract][Full Text] [Related]
15. Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system.
Kaur IP; Aggarwal D; Singh H; Kakkar S
Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1467-72. PubMed ID: 20437246
[TBL] [Abstract][Full Text] [Related]
16. Topical timolol, at conventional, unilateral doses causes bilateral ocular beta-blockade in rabbits.
Woodward DF; Dowling MC; Feldmann BJ; Chen J
Exp Eye Res; 1987 Feb; 44(2):319-29. PubMed ID: 2884125
[TBL] [Abstract][Full Text] [Related]
17. Transdermal iontophoretic delivery of timolol maleate in albino rabbits.
Kanikkannan N; Singh J; Ramarao P
Int J Pharm; 2000 Mar; 197(1-2):69-76. PubMed ID: 10704794
[TBL] [Abstract][Full Text] [Related]
18. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system.
Aggarwal D; Kaur IP
Int J Pharm; 2005 Feb; 290(1-2):155-9. PubMed ID: 15664141
[TBL] [Abstract][Full Text] [Related]
19. Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.
Urtti A; Rouhiainen H; Kaila T; Saano V
Pharm Res; 1994 Sep; 11(9):1278-82. PubMed ID: 7816756
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG).
Ohno Y; Iga T; Yamada Y; Nagahara M; Araie M; Takayanagi R
Curr Eye Res; 2005 Apr; 30(4):319-28. PubMed ID: 16020262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
